Jian Wu

Prof. Dr. Jian Wu

State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University, Huaxi District, Guiyang 550025, China.
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2014 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
JWJian Wu
Jian Wu
XDXianli Du
Xianli Du
JMJuan Ma
Juan Ma
YZYuping Zhang
Yuping Zhang
QSQingcai Shi
Qingcai Shi
DHDeyu Hu
Deyu Hu
A β-cyclodextrin-SO3H-assisted, convenient and efficient strategy for the preparation of 2,3-dihydroquinazolin-4(1H)-one derivatives in aqueous media is presented.

16 January 2023 in Frontiers in Plant Science
Verified
Journal Article
Open access
PSPing Sun
Ping Sun
YHYuanqin Huang
Yuanqin Huang
XYXiaoyan Yang
Xiaoyan Yang
ALAnjing Liao
Anjing Liao
JWJian Wu
Jian Wu
Indole compounds with their unique properties of mimicking peptide structures and reversible binding to enzymes are of great exploitative value in the regulation of plant growth. They stimulate root and fruit formation and activate the plant’s immune system against biotic and abiotic factors harmful to the plant. Analysis of target recognition, receptor recognition, key activation sites and activation mechanisms of indoles in plant to enhance crop growth or disease resistance is a crucial step for further developing compounds as plant growth regulators and immune inducers. Therefore, this review focused on the mechanism of action of indoles in regulating plant growth and enhancing plant resistance to biotic and abiotic stresses.

1 September 2018 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
YWYan-Yan Wang
Yan-Yan Wang
FXFang-Zhou Xu
Fang-Zhou Xu
YZYun-Ying Zhu
Yun-Ying Zhu
BSBaoan Song
Baoan Song
DLDexia Luo
Dexia Luo
JWJian Wu
Jian Wu

23 August 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
LYLijiao Yu
Lijiao Yu
ADAli Dai
Ali Dai
WZWei Zhang
Wei Zhang
ALAnjing Liao
Anjing Liao
SGShengxin Guo
Shengxin Guo
JWJian Wu
Jian Wu

29 August 2023 in Chinese Chemical Letters
Verified
Journal Article
Closed access
PSPing Sun
Ping Sun
YHYuanqin Huang
Yuanqin Huang
SCShunhong Chen
Shunhong Chen
XMXining Ma
Xining Ma
ZYZhaokai Yang
Zhaokai Yang
JWJian Wu
Jian Wu

12 June 2024 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
ZJZi-Chang Jia
Zi-Chang Jia
XYXue Yang
Xue Yang
YWYi-Kun Wu
Yi-Kun Wu
MLMin Li
Min Li
DDDebatosh Das
Debatosh Das
JWJian Wu
Jian Wu
Drug targets are specific molecules in biological tissues and body fluids that interact with drugs. Drug target discovery is a key component of drug discovery and is essential for the development of new drugs in areas such as cancer therapy and precision medicine. Traditional in vitro or in vivo target discovery methods are time-consuming and labor-intensive, limiting the pace of drug discovery. With the development of modern discovery methods, the discovery and application of various emerging technologies have greatly improved the efficiency of drug discovery, shortened the cycle time, and reduced the cost. This review provides a comprehensive overview of various emerging drug target discovery strategies, including computer-assisted approaches, drug affinity response target stability, multiomics analysis, gene editing, and nonsense-mediated mRNA degradation, and discusses the effectiveness and limitations of the various approaches, as well as their application in real cases. Through the review of the aforementioned contents, a general overview of the development of novel drug targets and disease treatment strategies will be provided, and a theoretical basis will be provided for those who are engaged in pharmaceutical science research. Significance Statement Target-based drug discovery has been the main approach to drug discovery in the pharmaceutical industry for the past three decades. Traditional drug target discovery methods based on in vivo or in vitro validation are time-consuming and costly, greatly limiting the development of new drugs. Therefore, the development and selection of new methods in the drug target discovery process is crucial.